AMSTERDAM, July 23, 2014 /PRNewswire/ --
QUOSA now offers customers with CCC licenses the full benefits of integration at no extra cost, significantly lowering barriers to copyright compliance
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that QUOSA, its literature management solution, and Copyright Clearance Center (CCC) have extended their relationship to support greater compliance in the use of full text articles within corporate or institutional environments. Using CCC's rights advisory API, QUOSA customers who are also CCC licensees can view their license rights directly from QUOSA at no extra cost to the user.
QUOSA users can instantly check the usage rights of documents within the QUOSA library by accessing the CCC database via a single user interface, helping them to quickly determine how they may use a document; for example, checking if they can share an article with colleagues. This significantly increases the efficiency of content management workflows, helping users manage large libraries of information and ensure compliance requirements are met. QUOSA and CCC first partnered in 2009; the expansion of this relationship will now deliver the same seamless functionality at no extra cost."Ensuring compliance is a mammoth task for both researchers and Information Managers alike. Users need to be sure they are using documents in a compliant manner and Information Managers must avoid the significant financial penalties that can result from failed compliance," said Daan de Jong, Director Product Development for Elsevier. "This latest enhancement to QUOSA supports our drive to make QUOSA the 'one stop shop' for literature management. Integrating QUOSA with per-article rights data at no extra cost takes away the uncertainty surrounding compliance that is experienced by pharmacovigilance and medical affairs personnel when accessing scientific literature." QUOSA is a centralized repository of scientific literature that enables life sciences institutions to meet regulatory reporting requirements, address medical inquiries and maintain current awareness in relation to topics or authors. It is used by a broad array of groups such as pharmacovigilance and medical affairs personnel in pharma, biotech and medical device companies. CCC is a leading global rights-licensing technology organization, providing solutions that simplify compliance for content users, promoting the work of creators and supporting the principles of copyright.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts